ER/LA Opioid REMS: Achieving Safe Use While Improving Patient Care
When
Monday April 6, 2015 from 6:30 PM to 8:30 PM CDT
Add to Calendar
Registration and heavy appetizers from 6-6:30. Program begins at 6:30.
Where
Crow River Golf Club915 Colorado St. NW
Hutchinson, MN 55350
Contact
Kathleen BaumbachMinnesota Medical Association
612-362-3729
kbaumbach@mnmed.org
It is the policy of the Minnesota Medical Association (MMA) to ensure balance, independence, objectivity, and scientific rigor in its CME activities. To comply with the Standards for Commercial Support of the Accreditation Council for Continuing Medical Education (ACCME), the MMA requires members of the planning committee and faculty to disclose the existence of any financial interest or other relationship he/she and his/her spouse or partner has with companies whose health care products or services are discussed in an educational presentation. The requirement applies to relationships that are in place at the time of the CME activity or in the 12 months preceding the activity.
The members of the faculty and planning committee for this conference have indicated that they have no relevant financial relationships to disclose related to the content of the CME activity.
Faculty members have declared that they will uphold the MMA's standards regarding CME activities and that any clinical recommendations are based on the best available evidence or are consistent with generally accepted medical practice. Please indicate in the comments section of the evaluation form whether you detect any instances of bias toward products manufactured by commercial interests.
Accreditation Statement:The Minnesota Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Minnesota Medical Association designates this live activity for a maximum of 2 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CME Provider contact informationJaime Olson, CME Manager
jolson@mnmed.org
612-362-3744
Minnesota Medical Association
1300 Godward St NE
Suite 2500
Minneapolis, MN 55413
Learning Objectives:
- Describe appropriate patient assessment for treatment with ER/LA opioid analgesics, evaluating risks and potential benefits of ER/LA therapy, as well as possible misuse.
- Apply proper methods to initiate therapy, modify dose, and discontinue use of ER/LA opioid analgesics, applying best practices including accurate dosing and conversion techniques as well as appropriate discontinuation strategies.
- Demonstrate accurate knowledge about how to manage ongoing therapy with ER/LA opioid analgesics, properly use evidence based tools while assessing for adverse effects.
- Employ methods to counsel patients and caregivers about the safe use of ER/LA opioid analgesics, including proper storage and disposal.
- Review/assess general and product-specific drug information concerning ER/LA opioid analgesics, identifying potential adverse effects of ER/LA opioids.
On July 9, 2012, the Food and Drug Administration (FDA) approved a risk evaluation and mitigation strategy (REMS) for extended-release (ER) and long-acting (LA) opioid medications. The Collaborative on REMS Education (CO*RE), a multidisciplinary collaboration of 10 Partners and three cooperating organizations, have designed a core curriculum based on needs assessment, practice gaps, clinical competencies, learner self-assessment, with shared tools, resources, and outcomes to meet the requirements of the FDA REMS Blueprint.
Who Should Attend
The intended audience is all prescribers of ER/LA Opioids and those whose occupation is affected by the prescription of ER/LA Opioids. This includes: pain specialists, primary care physicians, physician's assistants, advanced practice nurses, dentists, pharmacists, addiction medicine physicians, psychiatrists, neurologists, psychologists, and therapists.
More Information about CO*RE REMS
Review the FDA Curriculum Blueprint (click here)
Frequently Asked Questions (FAQ)
For more information about ER/LA Opioid REMS Courses, (click here)
Read the CO*RE Project Overview (click here)
Check out the CO*RE Website (click here)
“This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies. Please see http://ce.er-la-opioidrems.com/IwgCEUI/rems/pdf/List_of_RPC_Companies.pdf for a listing of the member companies. This activity is intended to be fully compliant with the ER/LA Opioid Analgesic REMS education requirements issued by the US Food & Drug Administration.”